Amphastar Pharmaceuticals, Inc. (AMPH)
27.54
-1.05
(-3.67%)
USD |
NASDAQ |
Feb 12, 16:00
27.54
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals EPS Diluted (Quarterly) : 0.3639 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.390 |
| Pfizer Inc. | -0.2898 |
| Catalyst Pharmaceuticals, Inc. | 0.4153 |
| Johnson & Johnson | 2.098 |
| CorMedix, Inc. | 1.259 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.35M |
| Revenue (Quarterly) | 191.84M |
| Total Expenses (Quarterly) | 174.49M |
| Enterprise Value | 1.692B |
| Gross Profit Margin (Quarterly) | 49.53% |
| Profit Margin (Quarterly) | 9.04% |
| Earnings Yield | 8.19% |
| Operating Earnings Yield | 11.05% |
| Normalized Earnings Yield | 8.100 |